July 18, 2019 | Iowa City, IA.
Viewpoint Molecular Targeting, Inc. and collaborators from the University of Iowa and the University of Missouri received acceptance notification from the peer-reviewed journal Molecular Pharmaceutics for the manuscript titled “Enhancing the efficacy of melanocortin 1 receptor-targeted radiotherapy by pharmacologically upregulating the receptor in metastatic melanoma.” Manuscript authors include: Li, Mengshi; Liu, Dijie; Lee, Dongyoul; Kapoor, Somya; Gibson-Corley, Katherine; Quinn, Thomas; Sagastume, Edwin; Mott, Sarah; Walsh, Susan; Acevedo, Michael; Johnson, Frances; and Schultz, Michael. This publication can be found in Molecular Pharmaceutics (Manuscript ID: mp-2019-00512p.R1.).
Web access: https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.9b00512